Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF.MI
Get informed when a big investor buys or sells
+ FollowMarket Cap$160.61M
Close$
Share Statistics
| Market cap | $160.61 Million |
|---|---|
| Enterprise Value | $273.09 Million |
| Dividend Yield | $0.16 (2.39%) |
| Earnings per Share | $0.4 |
| Beta | 0.91 |
| Outstanding Shares | 22,234,000 |
Return
| Return on Equity | -0.89% |
|---|---|
| Return on Assets | -0.33% |
| Return on Invested Capital | 1.99% |
Valuation & Multiples
| P/E Ratio | -102.29 |
|---|---|
| PEG | 60.87 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 1.34 |
| Enterprise Value to Revenue | 1.1 |
| Enterprise Value to EBIT | 61.03 |
| Enterprise Value to Net Income | -264 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 1.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 8, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$67.20 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$69.52 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fine Foods & Pharmaceuticals N.T.M. S.p.A.
1,123 employees
CEO: Marco Francesco Eigenmann Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development and manufacturing organization (CDMO), specializing in the creation of various oral solid forms for the pharmaceutical and nutraceutical sectors. Its pharmace...